861403-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient tralokinumab (Adtralza)

World Biggest Tenders Source

This tender with title 861403-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient tralokinumab (Adtralza) has been published on Bidding Source portal dated 29 Dec 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

861403-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient tralokinumab (Adtralza)

Tender Type :

Contract Award

Reference No. :

861403

Country :

Germany

Publish Date :

29 Dec 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

862014-Awarded - Germany – Pharmaceutical products – Cancellation of the open house procedure for lacosamide (excluding film-coated tablets), ATC N03AX18 Germany 861702-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient sodium phenylbutyrate LSE (Pheburane) Germany 860534-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient ertugliflozin (Steglatro) Germany 860331-Awarded - Germany – Pharmaceutical products – Cancellation of the open house procedure for calcipotriol and betamethasone, excluding ointments, ATC D05AX22 Germany 856012- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient solifenacin/tamsulosin (WHO ATC code: G04CA53) Germany 857590- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, by way of an open-house model for the active ingredient dexamethasone (WHO ATC code: S01BA01) Germany 846842- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the period from February 1, 2026 to, as a rule, January 31, 2028 Germany 847469-Awarded - Germany – Pharmaceutical products – Drug contracts with accession option Germany 840297- Germany – Pharmaceutical products – Medicinal products containing the active ingredient fentanyl (ATC: N02AB03 - except matrix patches and tablets) Germany 844138- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (open-house procedure) Germany

861403-Awarded - Germany – Pharmaceutical products – Announcement of awarded contracts pursuant to Section 130a Paragraph 8 SGB V and Section 130c SGB V for the active ingredient tralokinumab (Adtralza)

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com